# SonoThera funding rounds and investors

As of 14 Oct 2026, SonoThera has raised $125M across 1 verified round on record; latest: $125 million Series B led by Vida Ventures, announced 10 Jun 2026.

SonoThera develops innovative ultrasound-mediated nonviral genetic therapies targeting various medical conditions.

Website: https://sonothera.com  
Headquarters: San Francisco, California  
Page: https://fireround.dev/companies/sonothera.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-06-10 | Series B | $125 million | Vida Ventures | Alexandria Venture Investments, Arch Venture Partners, ARK Invest, CureDuchenne Ventures, Duquesne Family Office, Illumina Ventures, Leaps by Bayer, Medical Excellence Capital, Otsuka Pharmaceutical, RA Capital Management, SymBiosis, UCB Ventures, Vertex Ventures HC, Vivo Capital | [sonothera.com](https://sonothera.com/sonothera-closes-oversubscribed-125-million-series-b-financing-to-advance-clinical-development-of-ultrasound-mediated-nonviral-genetic-medicines), [businesswire.com](https://www.businesswire.com/news/home/20260610731032/en/SonoThera-Closes-Oversubscribed-%24125-Million-Series-B-Financing-to-Advance-Clinical-Development-of-Ultrasound-Mediated-Nonviral-Genetic-Medicines) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.